Cresp 100mcg Injection

About

Cresp 100mcg Injection contains Darbepoetin alfa, an erythropoiesis-stimulating agent (ESA). It functions by stimulating the bone marrow to produce red blood cells, thereby increasing the red blood cell count and hemoglobin levels in the body. This medication is primarily used to treat anemia associated with chronic kidney disease (CKD) in both dialysis and non-dialysis patients. It is also indicated for the treatment of anemia in certain cancer patients undergoing myelosuppressive chemotherapy, where the risk of transfusion is significant. Darbepoetin alfa is a longer-acting form of erythropoietin, requiring less frequent administration compared to epoetin alfa, which improves patient convenience and adherence. Its therapeutic effect helps to reduce the need for blood transfusions, improve energy levels, and enhance the overall quality of life for patients suffering from chronic anemia.

Uses

• Treatment of anemia associated with chronic kidney disease
• Management of anemia in cancer patients receiving chemotherapy
• Anemia in myelodysplastic syndromes
• Pre-operative anemia in certain surgical settings

Directions For Use

Administered subcutaneously or intravenously by a healthcare professional. Dosage is individualized based on patient's hemoglobin levels and clinical response.

Benefits

• Increases red blood cell count effectively
• Reduces the need for blood transfusions
• Improves energy levels and reduces fatigue
• Enhances overall quality of life for anemic patients
• Longer-acting formulation for less frequent dosing
• Supports cardiovascular health by correcting anemia

Side Effects

• Hypertension (high blood pressure)
• Thrombosis (blood clot formation)
• Injection site reactions (pain, redness, swelling)
• Headache
• Nausea and vomiting
• Diarrhea
• Rash or skin irritation
• Fever
• Peripheral edema (swelling of extremities)
• Seizures (rare)
• Allergic reactions
• Pure red cell aplasia (very rare)

Safety Measures

• Alcohol - No direct interaction, but excessive alcohol consumption can worsen anemia or liver function. Consult your doctor.
• Pregnancy - Use with caution during pregnancy. Potential risks versus benefits should be carefully assessed by a doctor.
• Breastfeeding - Consult a doctor before use during breastfeeding. Generally considered safe, but monitor the infant for any adverse effects.
• Liver - Use with caution in patients with severe liver impairment. Monitor liver function tests regularly.
• Kidney - Primarily used for anemia in chronic kidney disease. Dosage adjustments may be necessary based on kidney function and hemoglobin response.
• Lung - No specific contraindication, but monitor for symptoms of pulmonary embolism, especially in patients with a history of thrombotic events.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.